Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-professor-siew-ng-becomes-the-first-clinician-scientist-in-hong-kong-to-be-selected-as-a-new-cornerstone-investigator
https://www.med.cuhk.edu.hk/press-releases/cuhk-professor-siew-ng-becomes-the-first-clinician-scientist-in-hong-kong-to-be-selected-as-a-new-cornerstone-investigator

CUHK Professor Siew Ng becomes the first clinician-scientist in Hong Kong to be selected as a New Cornerstone Investigator

Professor Siew Ng from The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) was selected as a 2023 New Cornerstone Investigator under The New Cornerstone Investigator Program, which is a non-profit and independent fund initiated by Tencent. She is the first and only Hong Kong scholar in the field of Biology and Biomedical Sciences to receive the honour since the launch of the programme. Professor Ng will be awarded an initial five-year term grant with an annual budget of 5 million RMB for experimental research.

 

The New Cornerstone Investigator Program is one of the largest independent, nonprofit funding initiatives in mainland China. Based on the principle of “supporting people, not projects”, the programme aims to provide stable long-term support for a select group of exceptional scientists to carry out basic research, and take the leap “from 0 to 1”.

 

Approximately 600 outstanding scientists applied this year. After several rounds of rigorous evaluation by national and international experts, they chose 46 scientists from 13 Chinese cities in the fields of Mathematics & Physical Sciences and Biological & Biomedical Sciences to receive New Cornerstone Investigator Program funding.

 

Professor Siew Ng

Professor Siew Ng from CU Medicine was selected as 2023 New Cornerstone Investigator under The New Cornerstone Investigator Program.  She is the first and only Hong Kong scholar in the field of Biology and Biomedical Sciences to receive the honour since the launch of this program.  

 

Creating a paradigm shift in microbiome medicine

 

Professor Ng is a world-renowned researcher of the gut microbiome. Born in Penang, Malaysia, she went to the United Kingdom to study medicine, completing her PhD in 2009. In 2010, she moved to Hong Kong and joined CU Medicine. Professor Ng is currently the Assistant Dean (Development) of CU Medicine; a Professor in the Department of Medicine and Therapeutics; Associate Director of the Centre for Gut Microbiota Research; and Director of the Microbiota I-Center (MagIC). She has also been appointed the Croucher Professor in Medical Sciences, the very first named professorship bestowed by the Croucher Foundation.

 

Professor Ng first became intrigued with the germs in the gut during her PhD studies at Imperial College London and devoted herself to studying Inflammatory Bowel Disease (IBD), a chronic gastrointestinal disease that was then prevalent in the West but virtually unknown in Asia. With an indomitable spirit of curiosity, Professor Ng and her team were the first to define the epidemiology of IBD in Asia and reported that the incidence in Hong Kong had risen a staggering 30-fold in less than three decades. Since joining CU Medicine, she has been leading researchers from over 30 countries and regions in the Asia-Pacific region as they study the disease, bringing about a paradigm shift in public health regionally and globally. In 2021, global physician directory Expertscape listed Professor Ng as one of the world’s top 20 IBD researchers.

 

In 2013, Professor Ng introduced fecal microbiota transplantation (FMT) to Hong Kong to treat patients with life-threatening gut infections. In 2018, she established Asia’s first FMT research centre, which now serves as the sole provider of FMT services to more than 40 hospitals managed by the Hospital Authority in Hong Kong. In 2019, Professor Ng established the Microbiota I-Center (MagIC) as part of the HKSAR Government’s InnoHK initiative, and founded a biotechnology company that focuses on translating innovative microbiome solutions into effective diagnostics and therapeutics.

 

A receipient of landmark accolades and international honours in recent years

 

As a highly accomplished researcher, Professor Ng has published over 330 peer-reviewed papers in international journals, including The Lancet and Nature Genetics. Her research has received numerous awards, including the 2017 Sir David Todd Lectureship and the 2020 Ministry of Education Higher Education Outstanding Scientific Research Output Award – First-class Award in Natural Sciences, China’s highest honour in the field. She was named a highly cited researcher by analytics company Clarivate for three consecutive years, from 2020 to 2022, demonstrating significant and broad influence in her field of study through the publication of multiple papers which ranked in the top 1% by citations during the last decade. Recently, she received the Higher Flyer Innopreneur Award and the Most Popular Innopreneur Award from the Federation of Hong Kong Industries for her outstanding leadership in innovative technology.

 

Inspiring the next generation of scientists to join the quest for breakthrough discoveries

 

Professor Ng said she is grateful to be selected as a New Cornerstone Investigator. “This programme is unique and is not bounded by defined research projects or deadlines, allowing scientists the freedom and flexibility to develop wild ideas, explore uncharted territory and set foot in scientific areas where no one has ventured before. To answer the fundamental question of how the food we eat regulates the trillions of microbes in the gut that trigger inflammation and immune dysfunction, I will explore diet-microbiome-immune interactions to understand immunoregulatory mechanisms in response to dietary antigens, and introduce a new paradigm of novel therapeutic targets for chronic inflammatory and immune-mediated diseases.”

 

As one of the only five female scientists selected this year, representing 10% of the total, Professor Ng added that she feels deeply honoured. “I would like to extend my heartfelt gratitude to the committee for their recognition of our team’s effort. I am most grateful to my family, mentors and collaborators, who have inspired and supported me throughout my research journey, and to my devoted team, who have worked closely with me in the past decade to transform new concepts into clinical applications that ultimately benefit patients.” Professor Ng hopes that more young scientists will take bold steps and strive for innovations and breakthroughs that enhance human health.

 

About the New Cornerstone Investigator Program

 

The New Cornerstone Investigator Program is an independent, nonprofit funding initiative for basic research that focuses on original innovation and encourages free exploration. In 2022, Tencent pledged to provide RMB10 billion over 10 years to establish the New Cornerstone Investigator Program and facilitate exceptional scientists to devote themselves to basic research in a stable, long-term manner, realising original innovations from 0 to 1.

More Press Releases

Two CU Medicine scholars are elected as Foreign Members of the Academia Europaea

Two CU Medicine scholars are elected as Foreign Members of the Academia Europaea

Awards and honors
A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

Research
CU Medicine leads new clinical practice guidelines on use of non-invasive biomarkers for colorectal cancer screening with international experts

CU Medicine leads new clinical practice guidelines on use of non-invasive biomarkers for colorectal cancer screening with international experts

Research
CU Medicine’s population-based long COVID-19 survey estimates that over 400,000 recovered COVID-19 patients suffer from sexual dysfunction and reproductive problems

CU Medicine’s population-based long COVID-19 survey estimates that over 400,000 recovered COVID-19 patients suffer from sexual dysfunction and reproductive problems

Research
Inaugural Croucher Professorship in Medical Science lecture by Professor Siew Ng:   A Magical Pursuit

Inaugural Croucher Professorship in Medical Science lecture by Professor Siew Ng: A Magical Pursuit

Awards and honors
CUHK conducts interdisciplinary study on gut microbiota in pregnancy to reduce risk of inflammatory bowel disease in babies

CUHK conducts interdisciplinary study on gut microbiota in pregnancy to reduce risk of inflammatory bowel disease in babies

Research
CU Medicine supported by the Hospital Authority to launch HK’s first large-scale Long COVID survey, aiming to inform the government on impact of long COVID on healthcare services

CU Medicine supported by the Hospital Authority to launch HK’s first large-scale Long COVID survey, aiming to inform the government on impact of long COVID on healthcare services

Research
CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers  with Sensitivity Over 90%

CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers with Sensitivity Over 90%

Research
CU Medicine Study Suggests Toddlers are at High Risk of Being  “Silent Spreaders of SARS-CoV2 Infection”

CU Medicine Study Suggests Toddlers are at High Risk of Being “Silent Spreaders of SARS-CoV2 Infection”

Research
CU Medicine Study Shows Modulation of Gut Microbiota  Helps Enhance Safety and Efficacy of COVID-19 Vaccine

CU Medicine Study Shows Modulation of Gut Microbiota Helps Enhance Safety and Efficacy of COVID-19 Vaccine

Research
CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

Research
CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

Research
40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

Research
CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

Research
CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

Research
The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

Research
Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Awards and honors
CUHK Establishes Asia’s First Microbiota Transplantation and Research Centre Hope for New Strategies in Disease Prevention and Cure

CUHK Establishes Asia’s First Microbiota Transplantation and Research Centre Hope for New Strategies in Disease Prevention and Cure

Research
CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

Research
CUHK Announces World’s First Meta-analysis on Prevalence of Helicobacter pylori Infection

CUHK Announces World’s First Meta-analysis on Prevalence of Helicobacter pylori Infection

Research
CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

Research
CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

Research
CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

Research
Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.